Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-κB in Stressed Human Astroglial Cells and in Alzheimer Disease*
暂无分享,去创建一个
Yuhai Zhao | J. Cui | W. Lukiw | S. Bhattacharjee | Yuhai Zhao | Surjyadipta Bhattacharjee | Walter J Lukiw | Jian Guo Cui | Yuan Yuan Li | Y. Li
[1] Charles N Serhan,et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. , 2005, The Journal of clinical investigation.
[2] M. Ball,et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.
[3] Douglas G. Walker,et al. Postmortem interval effect on RNA and gene expression in human brain tissue , 2011, Cell and Tissue Banking.
[4] Isaac Yang,et al. The role of microglia in central nervous system immunity and glioma immunology , 2010, Journal of Clinical Neuroscience.
[5] Navin L Rao,et al. IRAK1: a critical signaling mediator of innate immunity. , 2008, Cellular signalling.
[6] Liwu Li,et al. Regulation of innate immunity signaling and its connection with human diseases. , 2004, Current drug targets. Inflammation and allergy.
[7] Walter J. Lukiw,et al. Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex , 2009, Neuroscience Letters.
[8] R. Mrak,et al. Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.
[9] W. Lukiw. Gene Expression Profiling in Fetal, Aged, and Alzheimer Hippocampus: A Continuum of Stress-Related Signaling , 2004, Neurochemical Research.
[10] Peter T. Nelson,et al. MicroRNAs (miRNAs) in Neurodegenerative Diseases , 2008, Brain pathology.
[11] Walter J. Lukiw,et al. Isolation of High Spectral Quality RNA Using Run-on Gene Transcription; Application to Gene Expression Profiling of Human Brain , 2005, Cellular and Molecular Neurobiology.
[12] M. Ball,et al. Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells , 2010, Neuroreport.
[13] N. Bazan,et al. Run-on gene transcription in human neocortical nuclei , 1998, Journal of Molecular Neuroscience.
[14] N. Bazan,et al. Cyclooxygenase-2 and Presenilin-1 Gene Expression Induced by Interleukin-1β and Amyloid β42 Peptide Is Potentiated by Hypoxia in Primary Human Neural Cells* , 2002, The Journal of Biological Chemistry.
[15] D. Baltimore,et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.
[16] J. Cui,et al. Natural secretory products of human neural and microvessel endothelial cells , 2007, Molecular Neurobiology.
[17] Yuhai Zhao,et al. Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. , 2009, Journal of inorganic biochemistry.
[18] Liwu Li,et al. The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation. , 2008, Cytokine.
[19] N. Bazan,et al. Strong nuclear factor‐κB‐DNA binding parallels cyclooxygenase‐2 gene transcription in aging and in sporadic alzheimer's disease superior temporal lobe neocortex , 1998, Journal of neuroscience research.
[20] J. Cui,et al. Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease , 2007, Neuroreport.
[21] K. Herkner,et al. MicroRNA-146: Tiny Player in Neonatal Innate Immunity? , 2010, Neonatology.
[22] A. Bowie,et al. IRAK-2 Participates in Multiple Toll-like Receptor Signaling Pathways to NFκB via Activation of TRAF6 Ubiquitination* , 2007, Journal of Biological Chemistry.
[23] K. Jellinger. Clinicopathological analysis of dementia disorders in the elderly--an update. , 2006, Journal of Alzheimer's disease : JAD.
[24] M. Lindsay,et al. microRNAs and the immune response. , 2008, Trends in immunology.
[25] J M Lee,et al. A gene expression profile of Alzheimer's disease. , 2001, DNA and cell biology.
[26] O. Forlenza,et al. Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment , 2009, Dementia and Geriatric Cognitive Disorders.
[27] Walter J. Lukiw,et al. An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells* , 2008, Journal of Biological Chemistry.
[28] Julie A Saugstad,et al. MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and Neurodegeneration , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] N. Bazan,et al. Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] K. Fassbender,et al. Innate immune receptor expression in normal brain aging , 2007, Neuroscience.
[31] R. Veerhuis,et al. Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease , 2010, Neurodegenerative Diseases.
[32] Norbert Schuff,et al. Mapping Alzheimer's Disease Progression in 1309 Mri Scans: Power Estimates for Different Inter-scan Intervals ☆ ⁎ and the Alzheimer's Disease Neuroimaging Initiative , 2022 .
[33] Jose Julio Rodriguez,et al. Astroglia in dementia and Alzheimer's disease , 2009, Cell Death and Differentiation.
[34] J. Tschopp,et al. IRAK2 takes its place in TLR signaling , 2008, Nature Immunology.
[35] W. Lukiw,et al. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. , 2007, Journal of inorganic biochemistry.
[36] Xi-sha Chen,et al. MicroRNA‐146a and Human Disease , 2010, Scandinavian journal of immunology.
[37] M. Lerman,et al. Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter. , 2005, Journal of molecular biology.
[38] M. Konsolaki,et al. The Toll→NFκB Signaling Pathway Mediates the Neuropathological Effects of the Human Alzheimer's Aβ42 Polypeptide in Drosophila , 2008, PloS one.
[39] S. Booth,et al. A miRNA Signature of Prion Induced Neurodegeneration , 2008, PloS one.
[40] J. C. Baayen,et al. Expression pattern of miR‐146a, an inflammation‐associated microRNA, in experimental and human temporal lobe epilepsy , 2010, The European journal of neuroscience.
[41] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[42] J. Mattick,et al. Non‐coding RNAs: regulators of disease , 2010, The Journal of pathology.
[43] W. Lukiw,et al. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.